Paulo Fontoura resigns from Lakefront Biotherapeutics board

Lakefront Biotherapeutics NV (NASDAQ: LKFT) announced that Dr. Paulo Fontoura has resigned from its Board of Directors following his appointment as Executive Vice President, Global Head of Research & Development Pharma at Sanofi SA.

Gino Santini, Chair of the Board of Directors, said: "I want to congratulate Paulo on this important assignment and sincerely thank him for his insight and guidance during his tenure on our Board. We wish him the best of luck in his new position and we expect to appoint a successor at the earliest practical opportunity."

Lakefront Biotherapeutics, formerly known as Galapagos, is a biotechnology company based in Mechelen, Belgium.

You May Also Be Interested In

• Robo.ai names three executives to lead UAE subsidiary Neurovia AI
• Autonomix Medical raises $2.6M via warrant inducement agreement
• CleanSpark signs $6.6B data center lease in Sandersville, Georgia